Skip to main content
. 2017 Jun 21;7:4005. doi: 10.1038/s41598-017-04198-3

Figure 5.

Figure 5

Spinal CXCR4-PLC-CaMKII pathway is involved in SDF-1-induced pain hypersensitivity. Intrathecal injection of exogenous SDF-1 (5 μg/10 μl) markedly induced mechanical allodynia (A,C and E) and thermal hyperalgesia (B,D and F) in a time-dependent manner. Post-administration of CXCR4 inhibitor Plerixafor (10 μg/10 μl, A and B), PLC inhibitor U73122 (10 nM/10 μl, C and D) or CaMKII inhibitor AIP2 (10 μM/10 μl, E and F), 30 min after SDF-1 injection, partially reversed SDF-1-induced nociceptive behaviors. The behavioral experiments between groups were performed at the same time points under the same experimental conditions. The same data of naive group and naive + SDF-1 group were rearranged and reused in A/C/E (threshold) and B/D/F (latency), respectively, to present the behavioral results more clearly and minimize the number of animals used. *P < 0.05, **P < 0.01 versus naive group; # P < 0.05, ## P < 0.01 vs naive + SDF-1 group; n = 8 for each group.